FRANKFURT, Aug 10 (Reuters) - Industrial group Siemens' (SIEGn.DE: Quote, Profile, Research) $6.8 billion acquisition of clinical diagnostics company Dade Behring (DADE.O: Quote, Profile, Research) will only contribute to the group's economic value in 2013, its finance chief said.
Joe Kaeser told German markets daily Boersen-Zeitung that Siemens had made an exception to its rule that acquisitions should be EVA-positive within three years in order to complete the last major piece of its diagnostics portfolio.
